US Patent 11318183 Stable pharmaceutical composition of vasopressin
Patent 11318183 was granted and assigned to Mankind Pharma Ltd on May, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Anil Kumar0
Ankush Gupta0
Hanumant Gambhire0
P. V. S Narasimham0
Raghuveera H. G0
Saurabh Kumar0
Edits on 26 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+358 characters)
US Patent 11318183 Stable pharmaceutical composition of vasopressin
Article
The present invention relates to a stable pharmaceutical composition comprising vasopressin or pharmaceutically acceptable salts thereof. The present invention further provides a method of increasing blood pressure in adults with vasodilatory shock by administering said pharmaceutical composition of vasopressin or pharmaceutically acceptable salts thereof.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11318183
Date of patent
May 3, 2022
Patent application number
16981892
Date Filed
March 15, 2019
Patent primary examiner
Find more entities like US Patent 11318183 Stable pharmaceutical composition of vasopressin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.